A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq ® (Pegvaliase) During Pregnancy and Breastfeeding
Condition: Phenylketonuria, Maternal Intervention: Drug: Pegvaliase Sponsors: BioMarin Pharmaceutical; Syneos Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials